2023 in review, CEO report cards, and a look at the year ahead

What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry.

More from STAT:

Become a subscriber: www.statnews.com/stat-plus/
Watch Full Episodes: youtube.com/@Statnews
Newsletters: www.statnews.com/signup/
STAT events: www.statnews.com/stat-events/
Facebook: www.facebook.com/statnews
Twitter: twitter.com/statnews
Instagram: www.instagram.com/statnews/
Flipboard: rb.gy/3xnsxr
STAT Reports: rb.gy/rexfwj
STAT eBooks: rb.gy/eme3h5

ABOUT STAT:
Founded in 2015, STAT is a global digital media brand that focuses on delivering fast, deep, and tough-minded journalism about the life sciences industries to over six million monthly site visitors and an additional 20 million readers on the Apple News app. STAT takes you inside academic labs, biotech boardrooms, and political backrooms, casting a critical eye on scientific discoveries, scrutinizing corporate strategies, and chronicling the roiling battles for talent, money, and market share. With an award-winning newsroom, STAT provides indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life sciences industry — and a revolution in human health.